PLIN4: A Protein Involved in Hematopoietic Stem Cell Proliferation and Multiple Diseases

Target Name: PLIN4

NCBI ID: G729359

PLIN4

PLIN4: A Protein Involved in Hematopoietic Stem Cell Proliferation and Multiple Diseases

PLIN4 (Promyelocytic leukemiainterleukin-4), also known as S3-12, is a protein that is expressed in a variety of tissues throughout the body. It is a key regulator of hematopoietic stem cell proliferation and has been implicated in the development and progression of many diseases, including leukemia.

PLIN4 is a member of the Interleukin-4 (IL4) family of cytokines, which are a group of cytokines that play a critical role in the regulation of immune and inflammatory responses. IL4 is a type of cytokine that is expressed in a variety of tissues throughout the body, including the lungs, gastrointestinal tract, skin, and hair.

PLIN4 is expressed in many different tissues throughout the body, including the lungs, liver, spleen, and lymphoid organs. It is a cytokine that is involved in the regulation of hematopoietic stem cell (HSC) proliferation, which is the process by which stem cells develop into fully developed blood cells.

PLIN4 is also involved in the regulation of T cell development and function. T cells are a type of immune cell that play a critical role in the regulation of the immune system, and PLIN4 is involved in the regulation of T cell development and function.

PLIN4 has also been shown to be involved in the regulation of inflammation. It is a cytokine that is involved in the regulation of inflammation and has been shown to play a role in the development of inflammatory diseases, such as rheumatoid arthritis and asthma.

PLIN4 is also involved in the regulation of cell survival. It is a cytokine that is involved in the regulation of cell survival and has been shown to play a role in the development of cancer.

PLIN4 is a potential drug target for the treatment of various diseases, including leukemia. It is a cytokine that is involved in the regulation of hematopoietic stem cell proliferation and has been shown to play a role in the development and progression of many diseases, including leukemia. By targeting PLIN4 with drugs, researchers may be able to treat these diseases and improve the quality of life for patients.

In conclusion, PLIN4 is a protein that is expressed in a variety of tissues throughout the body and is involved in the regulation of hematopoietic stem cell proliferation, T cell development and function, inflammation, and cell survival. It is a potential drug target for the treatment of various diseases, including leukemia. Further research is needed to fully understand the role of PLIN4 in these diseases and to develop effective treatments.

Protein Name: Perilipin 4

Functions: May play a role in triacylglycerol packaging into adipocytes. May function as a coat protein involved in the biogenesis of lipid droplets (By similarity)

The "PLIN4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLIN4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets